These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24339373)

  • 1. Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatments.
    Poulos C; Hauber AB; González JM; Turpcu A
    Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1008-15. PubMed ID: 24339373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment.
    Augustovski F; Beratarrechea A; Irazola V; Rubinstein F; Tesolin P; Gonzalez J; Lencina V; Scolnik M; Waimann C; Navarta D; Citera G; Soriano ER
    Value Health; 2013; 16(2):385-93. PubMed ID: 23538191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
    Harrison M; Marra C; Shojania K; Bansback N
    Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and parent preferences for immunoglobulin treatments: a conjoint analysis.
    Mohamed AF; Kilambi V; Luo MP; Iyer RG; Li-McLeod JM
    J Med Econ; 2012; 15(6):1183-91. PubMed ID: 22846048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective.
    Husni ME; Betts KA; Griffith J; Song Y; Ganguli A
    Rheumatol Int; 2017 Sep; 37(9):1423-1434. PubMed ID: 28623526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do Australian patients with inflammatory arthritis value in treatment? A discrete choice experiment.
    Ho KA; Acar M; Puig A; Hutas G; Fifer S
    Clin Rheumatol; 2020 Apr; 39(4):1077-1089. PubMed ID: 31858340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
    Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
    Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.
    Alten R; Nieto-Gonzalez JC; Jacques P; Montecucco C; Moots R; Radner H; Vonkeman HE; Heidenreich S; Whichello C; Krucien N; Van Beneden K
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38199605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment.
    Hazlewood GS; Bombardier C; Tomlinson G; Thorne C; Bykerk VP; Thompson A; Tin D; Marshall DA
    Rheumatology (Oxford); 2016 Nov; 55(11):1959-1968. PubMed ID: 27477807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies.
    Vass CM; Davison NJ; Vander Stichele G; Payne K
    Patient; 2020 Apr; 13(2):163-173. PubMed ID: 31565784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.
    Poulos C; Kinter E; van Beek J; Christensen K; Posner J
    Int J Technol Assess Health Care; 2018 Jan; 34(4):425-433. PubMed ID: 30251947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis.
    Bridges JF; Mohamed AF; Finnern HW; Woehl A; Hauber AB
    Lung Cancer; 2012 Jul; 77(1):224-31. PubMed ID: 22369719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.
    Johnson FR; Hauber AB; Ozdemir S; Lynd L
    Value Health; 2010; 13(4):418-23. PubMed ID: 20230550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study).
    Scarpato S; Antivalle M; Favalli EG; Nacci F; Frigelli S; Bartoli F; Bazzichi L; Minisola G; Matucci Cerinic M;
    Rheumatology (Oxford); 2010 Feb; 49(2):289-94. PubMed ID: 19920093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.
    Hifinger M; Hiligsmann M; Ramiro S; Watson V; Severens JL; Fautrel B; Uhlig T; van Vollenhoven R; Jacques P; Detert J; Canas da Silva J; Scirè CA; Berghea F; Carmona L; Péntek M; Keat A; Boonen A
    Ann Rheum Dis; 2017 Jan; 76(1):126-132. PubMed ID: 27190098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis.
    Iqbal I; Dasgupta B; Taylor P; Heron L; Pilling C
    J Med Econ; 2012; 15(6):1192-200. PubMed ID: 22804691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.
    Fraenkel L; Nowell WB; Michel G; Wiedmeyer C
    Ann Rheum Dis; 2018 May; 77(5):678-683. PubMed ID: 29247126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
    Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
    Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.